Drug Shortage Report for QUINSAIR
| Report ID | 258370 |
| Drug Identification Number | 02442302 |
| Brand name | QUINSAIR |
| Common or Proper name | levofloxacin |
| Company Name | HORIZON THERAPEUTICS IRELAND DAC |
| Market Status | MARKETED |
| Active Ingredient(s) | LEVOFLOXACIN |
| Strength(s) | 240MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INHALATION INHALATION |
| Packaging size | Nebulizer controller for new patients |
| ATC code | J01MA |
| ATC description | QUINOLONE ANTIBACTERIALS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2025-05-28 |
| Estimated end date | 2025-07-31 |
| Actual end date | 2025-07-11 |
| Shortage status | Resolved |
| Updated date | 2025-07-12 |
| Company comments | Temporary delay to new patient starts for QUINSAIR® due to a Horizon supply issue with the ZIRELA® Nebulizer controllers. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | POTTERY ROAD DUN LAOGHAIRE CO. DUBLIN, DUBLIN IRELAND A96F2A8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2025-07-12 | English | Compare |
| v7 | 2025-07-11 | French | Compare |
| v6 | 2025-07-11 | English | Compare |
| v5 | 2025-07-11 | English | Compare |
| v4 | 2025-05-29 | English | Compare |
| v3 | 2025-05-28 | French | Compare |
| v2 | 2025-05-28 | English | Compare |
| v1 | 2025-05-28 | English | Compare |
Showing 1 to 8 of 8